Colorectal Neoplasms Malignant

• CLINICAL_TRIALS trial_result · 2023-03-31
  Clinical Trial Update: Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC [Phase 2]

  Phase 2 trial evaluating tislelizumab plus cetuximab and irinotecan versus third-line standard-of-care in refractory metastatic colorectal c…

• CLINICAL_TRIALS trial_result · 2022-08-23
  Clinical Trial Update: FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage [Phase 2]

  A Phase 2 trial evaluating the combination of Fecal Microbiota Transplant (FMT) with an immune checkpoint inhibitor and a tyrosine kinase in…

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer [Phase 2]

  Phase 2 trial evaluating avelumab with cetuximab and irinotecan for treatment-refractory metastatic colorectal cancer that is microsatellite…

• CLINICAL_TRIALS trial_result · 2019-06-21
  Clinical Trial Update: A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer [Phase 1, Phase 2]

  Clinical trial update for CXD101 plus nivolumab in metastatic microsatellite-stable colorectal cancer (Phase 1/2).

• CLINICAL_TRIALS trial_result · 2018-09-26
  Clinical Trial Update: The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM [Phase 2, Phase 3]

  Clinical trial update investigating radiofrequency ablation combined with second-line chemotherapy and bevacizumab for unresectable colorect…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.